Akihiro Yokoyama   Akiko Kada   Toshiya Kagoo   Michihiro Hidake   Hiroatsu Iida   Yasuhiko Miyata   Akiko M. Saito   Morio Sawamura   Takuya Komeno   Kazutaka Sunami   Naoki Takezako   Hirokazu Nagai   
NAGOYA JOURNAL OF MEDICAL SCIENCE 84(1) 80-90 2022年2月
More than 40% of Japanese patients with multiple myeloma (MM) are over 75 years of age at diagnosis. Regardless of the treatment benefits, complications and relapses obstruct long-term survival. We conducted a phase II, open-label, single-arm, mul...